REQUEST A DEMO
Total
USD $0.00
Search more companies

Baird Medical Investment Holdings Ltd. (China)

Main Activities: Surgical and Medical Instrument Manufacturing
Full name: Baird Medical Investment Holdings Ltd. Profile Updated: April 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Baird Medical Investment Holdings Ltd. is engaged in the manufacturing of microwave ablation ("MWA") medical device. The company was established in 2012 and is headquartered in Guangzhou city, Guangdong province.

Headquarters
Room 202, 2/F, Baide Building, Building 11, No.15, Rongtong Street, Yuexiu District
Guangzhou; Guangdong;

Contact Details: Purchase the Baird Medical Investment Holdings Ltd. report to view the information.

Website: http://www.bairdmed.com

Basic Information
Total Employees:
Purchase the Baird Medical Investment Holdings Ltd. report to view the information.
Outstanding Shares:
Purchase the Baird Medical Investment Holdings Ltd. report to view the information.
Financial Auditors:
Purchase the Baird Medical Investment Holdings Ltd. report to view the information.
Incorporation Date:
December 07, 2025
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Chief Technology Officer
Purchase this report to view the information.
Chief Technology Officer
Purchase this report to view the information.
Director/Member of the Board
Subsidiaries
Baide Medical Investment Company Limited (Hong Kong SAR, China)
100%
Betters Medical Merger Sub. Inc. (United States)
100%
Guangzhou Dedao Capital Management Company Limited
100%
Company Performance
Financial values in the chart are available after Baird Medical Investment Holdings Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
19.01%
Total operating revenue
19.01%
Operating profit (EBIT)
17.24%
EBITDA
29.18%
Net Profit (Loss) for the Period
19.48%
Total assets
39.53%
Total equity
13.01%
Operating Profit Margin (ROS)
-0.6%
Net Profit Margin
0.14%
Return on Equity (ROE)
1.83%
Debt to Equity Ratio
21.82%
Quick Ratio
-0.31%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?